However, following treatment, tumor cells had increased expression of PD‐L1 and effector T cells had increased expression of CTLA4, suggesting immune checkpoint blockade in conjunction with CSF1R blockade may have a synergistic effect. Here, CTLA4 is linked to neoplasm.